相似文献
1
Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.
Am J Public Health. 2003 Nov;93(11):1871-7. doi: 10.2105/ajph.93.11.1871.
2
Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis.
Soc Sci Med. 2003 Apr;56(8):1789-96. doi: 10.1016/s0277-9536(02)00176-4.
3
Behavioral interventions for the control of tuberculosis among adolescents.
Public Health Rep. 2001 Nov-Dec;116(6):568-74. doi: 10.1093/phr/116.6.568.
4
Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection.
J Clin Epidemiol. 2005 Jun;58(6):645-8. doi: 10.1016/j.jclinepi.2004.11.022.
5
Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI).
Patient Educ Couns. 2004 Jan;52(1):31-9. doi: 10.1016/s0738-3991(02)00268-9.
6
Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles.
Int J Tuberc Lung Dis. 2004 Jun;8(6):703-10.
7
Urine testing to monitor adherence to TB preventive therapy.
J Clin Epidemiol. 2002 Mar;55(3):235-8. doi: 10.1016/s0895-4356(01)00470-x.
8
Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.
Chest. 2003 Mar;123(3):736-9. doi: 10.1378/chest.123.3.736.
9
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
BMC Infect Dis. 2006 Jun 13;6:97. doi: 10.1186/1471-2334-6-97.
10
Urine color test to monitor isoniazid compliance: "pissin' in the wind"?
Chest. 2003 Mar;123(3):668-70. doi: 10.1378/chest.123.3.668.
引用本文的文献
1
Earned Print and Digital Media in Advancing Hypertension Management Services in Punjab, India: A Descriptive Study.
Indian J Community Med. 2025 Sep-Oct;50(5):792-800. doi: 10.4103/ijcm.ijcm_264_23. Epub 2025 Feb 21.
2
Testing and Scaling Interventions to Improve the Tuberculosis Infection Care Cascade.
J Pediatric Infect Dis Soc. 2022 Oct 31;11(Supplement_3):S94-S100. doi: 10.1093/jpids/piac070.
3
Patient contracts for chronic medical conditions: Scoping review.
Can Fam Physician. 2022 May;68(5):e169-e177. doi: 10.46747/cfp.6805e169.
4
A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.
BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2020-004836.
5
Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation.
BMC Public Health. 2021 Jan 21;21(1):177. doi: 10.1186/s12889-021-10195-z.
6
Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies.
NPJ Prim Care Respir Med. 2020 May 11;30(1):21. doi: 10.1038/s41533-020-0179-x.
7
Interventions to Promote Oral Medication Adherence in the Pediatric Chronic Illness Population: A Systematic Review From the Children's Oncology Group.
J Pediatr Oncol Nurs. 2019 May/Jun;36(3):219-235. doi: 10.1177/1043454219835451. Epub 2019 Apr 4.
8
Lessons learned from two interventions designed to increase adherence to LTBI treatment in Latino youth.
Contemp Clin Trials Commun. 2018 Aug 16;12:129-136. doi: 10.1016/j.conctc.2018.08.002. eCollection 2018 Dec.
9
Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.
BMJ Open. 2017 Sep 15;7(9):e015108. doi: 10.1136/bmjopen-2016-015108.
10
Beyond pills and tests: addressing the social determinants of tuberculosis.
Clin Med (Lond). 2016 Dec;16(Suppl 6):s79-s91. doi: 10.7861/clinmedicine.16-6-s79.
本文引用的文献
1
A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
Drug Alcohol Depend. 2002 May 1;66(3):283-93. doi: 10.1016/s0376-8716(01)00208-3.
2
Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States.
South Med J. 2002 Apr;95(4):414-20.
3
From the Centers for Disease Control and Prevention. Tuberculosis morbidity among U.S.-born and foreign-born populations--United States, 2000.
MMWR Morb Mortal Wkly Rep. 2002 Feb 8;51(5):101-4.
4
Urine testing to monitor adherence to TB preventive therapy.
J Clin Epidemiol. 2002 Mar;55(3):235-8. doi: 10.1016/s0895-4356(01)00470-x.
5
Compliance to treatment of latent tuberculosis infection in a region of Israel.
Isr Med Assoc J. 2002 Jan;4(1):13-6.
6
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
Am J Med. 2001 Jun 1;110(8):610-5. doi: 10.1016/s0002-9343(01)00695-7.
7
Zip code-level risk factors for tuberculosis: neighborhood environment and residential segregation in New Jersey, 1985-1992.
Am J Public Health. 2001 May;91(5):734-41. doi: 10.2105/ajph.91.5.734.
8
A spoonful of sugar...: improving adherence to tuberculosis treatment using financial incentives.
Int J Tuberc Lung Dis. 2001 Jan;5(1):96-8.
9
Incentives vs outreach workers for latent tuberculosis treatment in drug users.
Am J Prev Med. 2001 Feb;20(2):103-7. doi: 10.1016/s0749-3797(00)00283-x.
10
Outcomes of contact investigations of infectious tuberculosis patients.
Am J Respir Crit Care Med. 2000 Dec;162(6):2033-8. doi: 10.1164/ajrccm.162.6.2004022.
Zotero 插件